531686 logo

MPS Pharmaa Limited Stock Price

BSE:531686 Community·₹33.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

531686 Share Price Performance

₹1.73
-1.01 (-36.86%)
₹1.73
-1.01 (-36.86%)
Price ₹1.73

531686 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with worrying balance sheet.

4 Risks
0 Rewards

MPS Pharmaa Limited Key Details

₹204.0

Revenue

₹179.0k

Cost of Revenue

-₹178.8k

Gross Profit

₹9.2m

Other Expenses

-₹9.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.49
-87,650.49%
-4,608,821.08%
1,162.9%
View Full Analysis

About 531686

Founded
1994
Employees
18
CEO
Peeyush Aggarwal
WebsiteView website
www.mpspharmaa.com

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-C. In addition, the company exports its products to East Asia, Southeast Asia, the Middle East, South America, and Africa. The company was formerly known as Advik Laboratories Limited and changed its name to MPS Pharmaa Limited in December 2022. MPS Pharmaa Limited was incorporated in 1994 and is based in New Delhi, India.

Recent 531686 News & Updates

Recent updates

No updates